Literature DB >> 7562125

Inadequacy of intravenous heparin therapy in the initial management of venous thromboembolism.

H N Lee1, D J Cook, A Sarabia, R Hatala, A McCallum, D King, G H Guyatt, J Dobranowski, P Powers.   

Abstract

To determine the adequacy of initial anticoagulation by intravenous heparin for patients who have deep venous thrombosis (DVT), and the factors that influence delayed anticoagulation, independent, duplicate chart review of 63 consecutive patients who had venography-proven DVT was conducted. Adequate heparinization (AH) was defined as an activated partial thromboplastin time (PTT) of more than 1.5 times the normal laboratory control. The proportions of patients achieving AH within 24 hours and 48 hours of initial heparin bolus were 46% and 62%, respectively. Patients who weighed more were less likely to achieve AH (p < 0.05), while patients receiving care from the thromboembolism service were more likely to achieve AH (p < 0.05). Low initial infusion rate was strongly but not significantly predictive of inadequate anticoagulation (p = 0.06). The mean heparin bolus and initial infusion rates were significantly lower than those suggested in the literature (p < 0.01). The AH rates were comparable to historical controls but suboptimal compared with the rates of 66% at 24 hours and 81% at 48 hours reported in association with heparin nomogram use (p < 0.05). A heparin nomogram is likely to achieve consistently higher rates of adequate heparinization.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7562125     DOI: 10.1007/BF02599954

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  15 in total

Review 1.  Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety.

Authors:  J Hirsh; J E Dalen; D Deykin; L Poller
Journal:  Chest       Date:  1992-10       Impact factor: 9.410

Review 2.  Antithrombotic therapy for venous thromboembolic disease.

Authors:  T M Hyers; R D Hull; J G Weg
Journal:  Chest       Date:  1992-10       Impact factor: 9.410

Review 3.  Venous thromboembolism.

Authors:  K M Moser
Journal:  Am Rev Respir Dis       Date:  1990-01

4.  A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time.

Authors:  D Basu; A Gallus; J Hirsh; J Cade
Journal:  N Engl J Med       Date:  1972-08-17       Impact factor: 91.245

5.  Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis.

Authors:  R D Hull; G E Raskob; J Hirsh; R M Jay; J R Leclerc; W H Geerts; D Rosenbloom; D L Sackett; C Anderson; L Harrison
Journal:  N Engl J Med       Date:  1986-10-30       Impact factor: 91.245

6.  Audit of control of heparin treatment.

Authors:  A G Fennerty; P Thomas; G Backhouse; P Bentley; I A Campbell; P A Routledge
Journal:  Br Med J (Clin Res Ed)       Date:  1985-01-05

7.  The weight-based heparin dosing nomogram compared with a "standard care" nomogram. A randomized controlled trial.

Authors:  R A Raschke; B M Reilly; J R Guidry; J R Fontana; S Srinivas
Journal:  Ann Intern Med       Date:  1993-11-01       Impact factor: 25.391

8.  Acenocoumarol and heparin compared with acenocoumarol alone in the initial treatment of proximal-vein thrombosis.

Authors:  D P Brandjes; H Heijboer; H R Büller; M de Rijk; H Jagt; J W ten Cate
Journal:  N Engl J Med       Date:  1992-11-19       Impact factor: 91.245

9.  Subcutaneous heparin compared with continuous intravenous heparin administration in the initial treatment of deep vein thrombosis. A meta-analysis.

Authors:  D W Hommes; A Bura; L Mazzolai; H R Büller; J W ten Cate
Journal:  Ann Intern Med       Date:  1992-02-15       Impact factor: 25.391

10.  Optimal therapeutic level of heparin therapy in patients with venous thrombosis.

Authors:  R D Hull; G E Raskob; D Rosenbloom; J Lemaire; G F Pineo; B Baylis; J S Ginsberg; A A Panju; P Brill-Edwards; R Brant
Journal:  Arch Intern Med       Date:  1992-08
View more
  3 in total

1.  Guidelines for anticoagulation therapy for venous thromboembolism.

Authors:  David K Cundiff
Journal:  J Gen Intern Med       Date:  2002-01       Impact factor: 5.128

2.  Do practice guidelines augment drug utilisation review?

Authors:  E A Chrischilles; K Gondek
Journal:  Pharmacoeconomics       Date:  1997-12       Impact factor: 4.981

3.  Teaching an old dog new tricks.

Authors:  J S Schwartz; D J Shulkin
Journal:  J Gen Intern Med       Date:  1995-06       Impact factor: 5.128

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.